Ann Lab Med.  2024 Jan;44(1):82-91. 10.3343/alm.2024.44.1.82.

Evaluation of Group Genetic Counseling Sessions via a Metaverse-based Application

• Yoo B
• Kim A
• Moon HS
• So MK
• Jeong TD
• Lee KE
• Moon BI
• Huh J

• KMID: 2550226
• DOI: http://doi.org/10.3343/alm.2024.44.1.82

Abstract

Background
Group genetic counseling has been implemented to meet growing demand. A metaverse platform, in which a society is built and activities are carried out in the virtual world, has not yet been implemented in group genetic counseling. We investigated whether a metaverse platform could be an alternative service-delivery model for group genetic counseling.
Methods
Participants (N=131) were divided into three groups: patient (N=45), family (N= 43), and interested (N = 43) groups. Participants entered the metaverse through a link sent to their mobile phones and attended a 20-min group genetic counseling session reviewing hereditary breast cancer, followed by a 10-min question-and-answer period.
Results
The overall median score of post-educational knowledge (9.0, range 8.0–10.0) significantly increased compared to that of pre-educational knowledge (6.0, range 3.0– 8.0) (P < 0.001). There was no significant difference in the pre- and post-educational knowledge scores among the three groups (P > 0.05). Most participants (95%) responded that their understanding of hereditary breast cancer had increased after the group genetic counseling session and that their satisfaction was high. The main advantage noted with metaverse was no limit of space and location while attending the session (97%), and the main disadvantage was a possibility of missing content due to an unstable internet connection (67%).
Conclusions
The metaverse platform would be acceptable as an alternative group genetic counseling service. More studies are needed to investigate how, for whom, and in what circumstances metaverse can be effectively utilized.

Keyword

Education; Genetic counseling; Group genetic counseling; Hereditary breast cancer; Metaverse

Figure

• 

  Fig. 1 Results of the group genetic counseling satisfaction survey.

Reference

1. Koo H. 2021; Training in lung cancer surgery through the metaverse, including extended reality, in the smart operating room of Seoul National University Bundang Hospital, Korea. J Educ Eval Health Prof. 18:33. DOI: 10.3352/jeehp.2021.18.33. PMID: 34965648. PMCID: PMC8810683.

2. Ifdil I, Situmorang DDB, Firman F, Zola N, Rangka IB, Fadli RP. 2023; Virtual reality in metaverse for future mental health-helping profession: an alternative solution to the mental health challenges of the COVID-19 pandemic. J Public Health. 45:e142–3. DOI: 10.1093/pubmed/fdac049. PMID: 35467746. PMCID: PMC9129134.

3. Namkoong K, Chen J, Leach J, Song Y, Vincent S, Byrd AP, et al. 2023; Virtual reality for public health: a study on a VR intervention to enhance occupational injury prevention. J Public Health. 45:136–44. DOI: 10.1093/pubmed/fdab407. PMID: 35051993.

4. Marr B. The amazing possibilities of healthcare in the metaverse. Forbes;https://www.forbes.com/sites/bernardmarr/2022/02/23/the-amazing-possibilities-of-healthcare-in-the-metaverse/?sh=67ba0bb49e5c. Updated on Feb 2022.

5. Jeon HY. Cha Ilsan Medical Hospital opens a hospital in Metaverse. Health Chosun News;https://m.health.chosun.com/svc/news_view.html?contid=2021061700992. Updated on June 2021.

6. Lee S. 'Get on the metaverse~' University hospital metaverse competition "in full swing. Point Daily;https://www.thekpm.com/news/articleView.html?idxno=121703. Updated on June 2022.

7. Erblich J, Brown K, Kim Y, Valdimarsdottir HB, Livingston BE, Bovbjerg DH. 2005; Development and validation of a Breast Cancer Genetic Counseling Knowledge Questionnaire. Patient Educ Couns. 56:182–91. DOI: 10.1016/j.pec.2004.02.007. PMID: 15653247.

8. Aziz A, Zork N, Aubey JJ, Baptiste CD, D'Alton ME, Emeruwa UN, et al. 2020; Telehealth for high-risk pregnancies in the setting of the COVID-19 pandemic. Am J Perinatol. 37:800–8. DOI: 10.1055/s-0040-1712121. PMID: 32396948. PMCID: PMC7356069.

9. Dratch L, Paul RA, Baldwin A, Brzozowski M, Gonzalez-Alegre P, Tropea TF, et al. 2021; Transitioning to telegenetics in the COVID-19 era: patient satisfaction with remote genetic counseling in adult neurology. J Genet Couns. 30:974–83. DOI: 10.1002/jgc4.1470. PMID: 34265143. PMCID: PMC8427091.

10. Uhlmann WR, McKeon AJ, Wang C. 2021; Genetic counseling, virtual visits, and equity in the era of COVID-19 and beyond. J Genet Couns. 30:1038–45. DOI: 10.1002/jgc4.1469. PMID: 34291525. PMCID: PMC8426877.

11. Danylchuk NR, Cook L, Shane-Carson KP, Cacioppo CN, Hardy MW, Nusbaum R, et al. 2021; Telehealth for genetic counseling: A systematic evidence review. J Genet Couns. 30:1361–78. DOI: 10.1002/jgc4.1481. PMID: 34355839.

12. Lohn Z, Fok A, Richardson M, Derocher H, Mung SW, Nuk J, et al. 2022; Large-scale group genetic counseling: evaluation of a novel service delivery model in a Canadian hereditary cancer clinic. J Genet Couns. 31:459–69. DOI: 10.1002/jgc4.1512. PMID: 34596310.

13. Cloutier M, Gallagher L, Goldsmith C, Akiki S, Barrowman N, Morrison S. 2017; Group genetic counseling: an alternate service delivery model in a high risk prenatal screening population. Prenat Diagn. 37:1112–9. DOI: 10.1002/pd.5149. PMID: 28873215.

14. Hynes J, MacMillan A, Fernandez S, Jacob K, Carter S, Predham S, et al. 2020; Group plus "mini" individual pre-test genetic counselling sessions for hereditary cancer shorten provider time and improve patient satisfaction. Hered Cancer Clin Pract. 18:3. DOI: 10.1186/s13053-020-0136-2. PMID: 32099586. PMCID: PMC7029530.

15. Spiers J, Smith JA, Ferrer-Duch M, Moldovan R, Roche J, MacLeod R. 2020; Evaluating a genetic counseling narrative group session for people who have tested positive for the Huntington's disease expansion: an interpretative phenomenological analysis. J Genet Couns. 29:1015–25. DOI: 10.1002/jgc4.1229. PMID: 32077165.

16. Peshkin BN, Kelly S, Nusbaum RH, Similuk M, DeMarco TA, Hooker GW, et al. 2016; Patient perceptions of telephone vs. in-person BRCA1/BRCA2 genetic counseling. J Genet Couns. 25:472–82. DOI: 10.1007/s10897-015-9897-6. PMID: 26455498. PMCID: PMC4829475.

17. Buchanan AH, Rahm AK, Williams JL. 2016; Alternate service delivery models in cancer genetic counseling: A mini-review. Front Oncol. 6:120. DOI: 10.3389/fonc.2016.00120. PMID: 27242960. PMCID: PMC4865495.

18. Greenberg SE, Boothe E, Delaney CL, Noss R, Cohen SA. 2020; Genetic counseling service delivery models in the United States: assessment of changes in use from 2010 to 2017. J Genet Couns. 29:1126–41. DOI: 10.1002/jgc4.1265. PMID: 32314856.